Innoviva Inc (INVA)
Innoviva Market Cap: 997.87M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 17, 2024 | 997.87M |
May 16, 2024 | 997.87M |
May 15, 2024 | 989.13M |
May 14, 2024 | 1.006B |
May 13, 2024 | 1.011B |
May 10, 2024 | 974.14M |
May 09, 2024 | 954.78M |
May 08, 2024 | 971.64M |
May 07, 2024 | 969.77M |
May 06, 2024 | 964.77M |
May 03, 2024 | 949.16M |
May 02, 2024 | 959.78M |
May 01, 2024 | 951.03M |
April 30, 2024 | 943.54M |
April 29, 2024 | 971.54M |
April 26, 2024 | 954.03M |
April 25, 2024 | 937.15M |
April 24, 2024 | 947.78M |
April 23, 2024 | 948.41M |
April 22, 2024 | 933.40M |
April 19, 2024 | 934.65M |
April 18, 2024 | 918.40M |
April 17, 2024 | 909.30M |
April 16, 2024 | 908.67M |
April 15, 2024 | 904.28M |
Date | Value |
---|---|
April 12, 2024 | 918.72M |
April 11, 2024 | 923.74M |
April 10, 2024 | 916.84M |
April 09, 2024 | 924.37M |
April 08, 2024 | 925.00M |
April 05, 2024 | 920.60M |
April 04, 2024 | 920.60M |
April 03, 2024 | 930.02M |
April 02, 2024 | 929.40M |
April 01, 2024 | 955.14M |
March 28, 2024 | 963.58M |
March 27, 2024 | 966.75M |
March 26, 2024 | 947.14M |
March 25, 2024 | 954.10M |
March 22, 2024 | 954.10M |
March 21, 2024 | 947.78M |
March 20, 2024 | 935.13M |
March 19, 2024 | 925.02M |
March 18, 2024 | 920.59M |
March 15, 2024 | 939.56M |
March 14, 2024 | 930.71M |
March 13, 2024 | 932.60M |
March 12, 2024 | 937.03M |
March 11, 2024 | 935.13M |
March 08, 2024 | 938.29M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
NovaBay Pharmaceuticals Inc | 4.487M |
Palatin Technologies Inc | 32.27M |
iBio Inc | 6.899M |
Theriva Biologics Inc | 6.405M |
Oragenics Inc | 10.44M |
Market Cap Related Metrics
PE Ratio | 7.198 |
PS Ratio | 4.118 |
Price to Book Value | 1.418 |
Price to Free Cash Flow | 8.418 |
Price | 15.98 |
Earnings Yield | 13.89% |
Operating PE Ratio | 11.69 |
Normalized PE Ratio | 7.169 |